Course Name Credits Type Course Format Release and expiration date
How checkpoint inhibitors are changing the treatment paradigm in solid tumors: what advanced practitioners in oncology should know
  • 1.10 ANCC credits
  • 1.10 Attendance credits
Enduring
  • Online CME
07/12/2016 to 07/11/2017
The 2016 Advanced Clinical Educator Program in Multiple Myeloma: A CE-Certified Serial Learning Approach to Bridging Communication and Educational... Enduring
  • Online CME
09/08/2016 to 09/07/2017
The Role of CDK 4/6 Inhibitors in the Management of Breast Cancer
  • 0.75 Attendance credits
  • 0.75 AMA PRA Category 1 Credit™ credits
Enduring
  • Online CME
07/01/2016 to 06/30/2017
New Directions in Soft-Tissue Sarcomas Other Than GIST For Community Oncology Centers
  • 1.00 ACPE credit
  • 1.00 ANCC credit
  • 1.00 AMA PRA Category 1 Credit™ credit
Enduring
  • Online CME
10/03/2016 to 10/02/2017
New Directions in Soft-Tissue Sarcomas Other Than GIST: A Focus on Sarcoma Centers
  • 1.00 ACPE credit
  • 1.00 ANCC credit
  • 1.00 AMA PRA Category 1 Credit™ credit
Enduring
  • Online CME
10/03/2016 to 10/02/2017
Managing Metastatic NSCLC: Strategies for Treatment Selection
  • 1.00 ACPE credit
  • 1.00 ANCC credit
  • 1.00 AMA PRA Category 1 Credit™ credit
Enduring
  • Online CME
07/12/2016 to 01/05/2018
Multiple Myeloma Disease Overview and Diagnostic Workup: Part of the 2016 Advanced Clinical Educator Program in Multiple Myeloma
  • 1.00 ANCC credit
Enduring
  • Online CME
02/28/2017 to 06/16/2017
Treatment of Multiple Myeloma in the First-Line, Maintenance, and Relapsed/Refractory Settings: Part of the 2016 Advanced Clinical Educator Program...
  • 1.00 ANCC credit
Enduring
  • Online CME
02/28/2017 to 06/16/2017
Survivorship and Side Effect Management in Patients With Multiple Myeloma: Part of the 2016 Advanced Clinical Educator Program in Multiple Myeloma
  • 1.00 ANCC credit
Enduring
  • Online CME
02/28/2017 to 06/16/2017
Making Progress for Improving Patient Lives: Clinical Advances in the First-Line Treatment of Advanced Squamous Non—Small Cell Lung Cancer
  • 1.00 ANCC credit
  • 1.00 Attendance credit
  • 1.00 AMA PRA Category 1 Credit™ credit
Enduring
  • Online CME
08/23/2016 to 12/15/2017
Understanding Treatment Strategies for Squamous Cell Carcinoma of the Head and Neck
  • 0.75 ANCC credits
  • 0.75 Attendance credits
  • 0.75 AMA PRA Category 1 Credit™ credits
Enduring
  • Online CME
12/13/2016 to 12/12/2017
Paving the Way to Better Choices for Veterans With Lung Cancer: A Shared Decision-Making Approach to Treatment
  • 1.00 ANCC credit
  • 1.00 Attendance credit
  • 1.00 AMA PRA Category 1 Credit™ credit
Enduring
  • Online CME
09/20/2016 to 03/30/2018
Managing Unresectable Hepatocellular Carcinoma: Focus on Systemic Therapies
  • 1.00 ANCC credit
  • 1.00 Attendance credit
  • 1.00 AMA PRA Category 1 Credit™ credit
Enduring
  • Online CME
09/28/2016 to 02/02/2018
CDK 4/6 Inhibitors: New Choices for HR-Positive, HER2-Negative Metastatic Breast Cancer
  • 1.00 ANCC credit
  • 1.00 Attendance credit
  • 1.00 AMA PRA Category 1 Credit™ credit
Enduring
  • Online CME
09/13/2016 to 05/02/2018
Nursing Clinical Insights Into the Benefits and Challenges of EGFR TKIs in the Treatment of NSCLC
  • 0.50 ANCC credits
  • 0.50 Attendance credits
Enduring
  • Online CME
01/18/2017 to 01/17/2018

Pages